Aligos Therapeutics

0 followers

Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.

Industries

Employees

51-200

Links


Org chart

Lawrence M. Blatt
Chief Executive Officer
Collapse
Lesley Ann Calhoun
EVP, Chief Financial Officer
Lucinda Y. Quan
EVP, Chief Business Officer & General Counsel
Julian A. Symons
EVP & Chief Scientific Officer
Dave Smith
Executive Vice President
Kha le
Executive Director
David B. Smith
EVP & Head of Chemical Operations
Ramon Polo
Senior Vice President, Head Global Regulatory Affairs
Sushmita Chanda, PhD, DABT
Chief Development Officer
Sushmita M. Chanda
Chief Development Officer
Jim Hassard
Chief Commercial Officer

Board & advisors

Jack B. Nielsen
Chairman / Lead Director
James Scopa
Director